MintPharma Capital

At MintPharma Capital, we are passionate about investing in biotech innovation. We believe in the transformative power of life-changing sciences and are committed to supporting dynamic companies at the forefront of this field. Investing in biotech innovation is challenging. Our team includes seasoned professionals with deep expertise as operators in the biotech and life sciences industry, who bring a wealth of knowledge and insights to our investment decisions and provide hands-on guidance to help our portfolio companies succeed. Investment Criteria ▪Typical Investment Size $2–5 million ▪Seed or Series A We often act as the lead investor in seed or Series A rounds. ▪Development Stage We focus on very late-stage pre-clinical and early-stage clinical biotech and pharmaceutical companies, where successful outcomes can create significant value. ▪First-in-Class We look for new or first-in-class therapies in areas where no FDA-approved treatment currently exists. ▪Market Opportunity We target companies with innovative therapies in government-protected reimbursement classes and prefer large commercial markets with significant unmet need. ▪Healthcare Economics We look for opportunities to improve patients’ lives while reducing the overall financial burden on patients and insurers.